Facial Aesthetics Market Size- By Product, By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2032

Description

Global Facial Aesthetics Market Overview:

According to SPER Market Research, the Global Facial Aesthetics Market is estimated to reach USD 31.04 billion by 2032 with a CAGR of 15.72%.

A non-invasive aesthetic process called facial aesthetics is used to treat skin issues such scars, acne, hyperpigmentation, wrinkles, dark skin, and stretch marks. Various facial aesthetic procedures, including microdermabrasion, chemical peels, dermal fillers, botulinum toxin, and cosmetic implants, are used to enhance aesthetic appeal. Dermal fillers used in facial cosmetic operations include hyaluronic acid, calcium hydroxyapatite, poly-L-lactic acid, and polymethyl-methacrylate microspheres. The rise in female population, the number of key players offering various facial aesthetic products, the number of procedures performed on the face, the number of products that key players have approved, and the number of procedures performed on the face all contribute to the growth of the global facial aesthetics market.

Impact of COVID-19 on the Global Facial Aesthetics Market:

It is projected that the COVID-19 epidemic will negatively affect the development of the global face aesthetics market. To boost hospital capacity for COVID-19 patients, a number of clinics and hospitals were reorganized. Surgery that wasn't absolutely necessary was postponed because of the pandemic. The non-emergency nature of facial aesthetics procedures severely limited the earnings of aesthetic businesses. Additionally, it is projected that the market for facial aesthetics will be negatively impacted by the sudden abrupt fall in people's monthly income.

Scope of the Report:

Market size available for years: 2019-2032

Base year considered: 2021

Forecast period: 2022-2032

Segments covered: By Product, By Application, By End User.

Regions covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Companies Covered: Candela Syneron, Evolus Inc, Sinclair Pharmaceuticals Limited, Abbvie Inc, Anika Therapeutics, Bausch Health Companies Inc, Cutera Inc, Cynosure, Fotona D.O.O, Galderma Laboratories, Ipsen, Johnsons & Johnsons, Merz Pharma, Revance Therapeutics, Teoxane.

Global Facial Aesthetics Market Segmentation:

By Product: Based on the Product, Global Facial Aesthetics Market is segmented as; Dermal Fillers (Hyaluronic Acid, Calcium Hydroxyapatite, Poly-L-lactic Acid, Polymethyl- methacrylate Microspheres, Others), Botulinum Toxin, Microdermabrasion, Chemical Peels, Others.

By Application: Based on the Application, Global Facial Aesthetics Market is segmented as; Facial Line Correction Treatment, Scar Treatment, Lip Enhancement, Restoration of Volume/Fullness, Others.

By End User: Based on the End User, Global Facial Aesthetics Market is segmented as; Specialty & Dermatology Clinics, Hospitals, Others.

By Region: North America owns the high share of this request; the major factors of the request's growth in the region are the adding prevalence of habitual ails, the growing quantum of drug conventions brought on by the region's fleetly growing population, and the expansion of crucial request actors in the area.

Product Code: HLCA2232

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1 Research data source
- 2.1.1 Secondary data
- 2.1.2 Primary data
- 2.1.3 SPER's internal database
- 2.1.4 Premium insight from KOL's
2.2 Market size estimation
- 2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1 Drivers
- 4.1.2 Restraints
- 4.1.3 Opportunities
- 4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Facial Aesthetics Market

5. Market variables and outlook

5.1. SWOT analysis
- 5.1.1 Strengths
- 5.1.2 Weaknesses
- 5.1.3 Opportunities
- 5.1.4 Threats
5.2. PESTEL analysis
- 5.2.1 Political landscape
- 5.2.2 Economic landscape
- 5.2.3 Social landscape
- 5.2.4 Technological landscape
- 5.2.5 Environmental landscape
- 5.2.6 Legal landscape
5.3. PORTER'S five forces analysis
- 5.3.1 Bargaining power of suppliers
- 5.3.2 Bargaining power of Buyers
- 5.3.3 Threat of Substitute
- 5.3.4 Threat of new entrant
- 5.3.5 Competitive rivalry
5.4. Heat map analysis

6. Global Facial Aesthetics Market, By Product, 2019-2032 (USD Million)

6.1. Dermal Fillers
- 6.1.1. Hyaluronic Acid
- 6.1.2. Calcium Hydroxyapatite
- 6.1.3. Poly-L-lactic Acid
- 6.1.4. Polymethyl- methacrylate Microspheres
- 6.1.5. Others
6.2. Botulinum Toxin
6.3. Microdermabrasion
6.4. Chemical Peels
6.5. Others

7. Global Facial Aesthetics Market, By Application, 2019-2032 (USD Million)

7.1. Facial Line Correction Treatment
7.2. Scar Treatment
7.3. Lip Enhancement
7.4. Restoration of Volume/Fullness
7.5. Others

8. Global Facial Aesthetics Market, By End User, 2019-2032 (USD Million)

8.1 Specialty & Dermatology Clinics
8.2 Hospitals
8.3 Others

9. Global Facial Aesthetics Market, By Region, 2019-2032 (USD Million)

9.1 North America
- 9.1.1 United States
- 9.1.2 Canada
- 9.1.3 Mexico
9.2 Europe
- 9.2.1 Germany
- 9.2.2 United Kingdom
- 9.2.3 France
- 9.2.4 Italy
- 9.2.5 Spain
- 9.2.6 Rest of Europe
9.3 Asia-Pacific
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 Australia
- 9.3.5 South Korea
- 9.3.6 Rest of Asia-Pacific
9.4 South America
- 9.4.1 Brazil
- 9.4.2 Argentina
- 9.4.3 Rest of South America
9.5 Middle East & Africa
- 9.5.1 Kingdom of Saudi Arabia
- 9.5.2 United Arab Emirates
- 9.5.3 Rest of Middle East & Africa

10. Company Profiles

10.1. Candela Syneron
- 10.1.1 Company details
- 10.1.2 Financial outlook
- 10.1.3 Product summary
- 10.1.4 Recent developments
10.2. Evolus Inc
- 10.2.1 Company details
- 10.2.2 Financial outlook
- 10.2.3 Product summary
- 10.2.4 Recent developments
10.3. Sinclair Pharmaceuticals Limited
- 10.3.1 Company details
- 10.3.2 Financial outlook
- 10.3.3 Product summary
- 10.3.4 Recent developments
10.4. Abbvie Inc
- 10.4.1 Company details
- 10.4.2 Financial outlook
- 10.4.3 Product summary
- 10.4.4 Recent developments
10.5. Anika Therapeutics
- 10.5.1 Company details
- 10.5.2 Financial outlook
- 10.5.3 Product summary
- 10.5.4 Recent developments
10.6. Bausch Health Companies Inc
- 10.6.1 Company details
- 10.6.2 Financial outlook
- 10.6.3 Product summary
- 10.6.4 Recent developments
10.7. Cutera Inc
- 10.7.1 Company details
- 10.7.2 Financial outlook
- 10.7.3 Product summary
- 10.7.4 Recent developments
10.8. Cynosure
- 10.8.1 Company details
- 10.8.2 Financial outlook
- 10.8.3 Product summary
- 10.8.4 Recent developments
10.9. Fotona D.O.O
- 10.9.1 Company details
- 10.9.2 Financial outlook
- 10.9.3 Product summary
- 10.9.4 Recent developments
10.10. Galderma Laboratories
- 10.10.1 Company details
- 10.10.2 Financial outlook
- 10.10.3 Product summary
- 10.10.4 Recent developments
10.11. Ipsen
- 10.11.1 Company details
- 10.11.2 Financial outlook
- 10.11.3 Product summary
- 10.11.4 Recent developments
10.12. Johnson and Johnson
- 10.12.1 Company details
- 10.12.2 Financial outlook
- 10.12.3 Product summary
- 10.12.4 Recent developments
10.13. Merz Pharma
- 10.13.1 Company details
- 10.13.2 Financial outlook
- 10.13.3 Product summary
- 10.13.4 Recent developments
10.14. Revance Therapeutics.
- 10.14.1 Company details
- 10.14.2 Financial outlook
- 10.14.3 Product summary
- 10.14.4 Recent developments
10.15. Teoxane
- 10.15.1 Company details
- 10.15.2 Financial outlook
- 10.15.3 Product summary
- 10.15.4 Recent developments